← Back to Search

ABMT for Childhood Anxiety Disorders

N/A

Waitlist Available

Led By Daniel Pine, M.D.

Research Sponsored by National Institutes of Health Clinical Center (CC)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up weeks 3, 8, and 12

Awards & highlights

Study Summary

This trial is examining whether a computer-based attention bias modification training can help augment individual cognitive behavioral therapy for pediatric anxiety.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ weeks 3, 8, and 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~weeks 3, 8, and 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 3, 8, and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical Global Impression of Improvement Scale

Pediatric Anxiety Rating Scale

Secondary outcome measures

Children's Global Assessment Scale

Screen for Child Anxiety Related Disorders

Self-Efficacy Questionnaire

+1 more

Side effects data

From 2016 Phase 4 trial • 8 Patients • NCT01833897

38%

sedation

25%

headache

13%

phosphenes

13%

hypomania

100%

80%

60%

40%

20%

Study treatment Arm

Ketamine and DCS Treatment

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Active InterventionExperimental Treatment1 Intervention

Children and adolescent participants with anxiety disorder receive cognitive behavioral therapy (CBT) for a 12-week period. In the final eight weeks of the trial, the subjects complete the Active Attention Bias Modification Training (ABMT), computer-based attention bias modification training aimed at re-training attentional biases before a CBT session: Part 1. modified dot-probe task, where a target is always presented at the previous location of the neutral and not the simultaneously presented threatening stimulus. Part 2. visual search, where the targets are always presented distally of threatening distractors.

Group II: Control InterventionPlacebo Group1 Intervention

Children and adolescent participants with anxiety disorder receive cognitive behavioral therapy (CBT) for a 12-week period. In the final eight weeks of the trial, the subjects complete the control intervention before a CBT session: Part 1. dot-probe task, where a target is equally randomly presented at the previous location of the neutral or the simultaneously presented threatening stimulus. Part 2. visual search, where the targets are equally randomly presented distal of neutral and threatening distractors.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Active Attention Bias Modification Training

2016

N/A

~130

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institutes of Health Clinical Center (CC)Lead Sponsor

383 Previous Clinical Trials

881,077 Total Patients Enrolled

Daniel Pine, M.D.Principal InvestigatorNational Institute of Mental Health (NIMH)

Media Library

Active Attention Bias Modification Training Clinical Trial Eligibility Overview. Trial Name: NCT03283930 — N/A

Anxiety Disorders Research Study Groups: Active Intervention, Control Intervention

Anxiety Disorders Clinical Trial 2023: Active Attention Bias Modification Training Highlights & Side Effects. Trial Name: NCT03283930 — N/A

Active Attention Bias Modification Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03283930 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to volunteer for this research project?

"To qualify for this anxiety disorder trial, participants must lie within the range of 8 and 17 years old. As of now, approximately 120 individuals are being sought after to fill spots in the clinical trial."

Answered by AI

To what extent has the capacity for this research project been maximized?

"Affirmative. According to clinicaltrials.gov, this medical research trial is still recruiting patients for participation. It was posted on December 1st 2016 and last updated April 4th 2022; it requires 120 individuals from a single clinic location."

Answered by AI

Does this medical experiment permit minors to participate?

"This clinical trial has outlined that the minimum age requirement to enrol is 8 years old, with 17 being the absolute upper limit."

Answered by AI

Are there any openings left in this clinical trial?

"Affirmative. Clinicaltrials.gov retains data that attests to this medical trial's active recruitment process, which began on December 1st 2016 and was most recently updated on April 4th 2022. 120 participants must be recruited from a single site for the investigation to progress properly."

Answered by AI